SCHEMBL698585

SCHEMBL698585

Cc1ccc(COC(=O)n2ccnc2[C@@H](C)c2cccc(C)c2C)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.36
KDM5A P29375 1/20 0.36
KDM2B Q8NHM5 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
GRIN2B Q13224 1/20 0.33
KMT2A Q03164 3/20 0.32
TP53 P04637 2/20 0.32
ALOX15 P16050 2/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL697345 0.91 NPC1 (0.38) KDM4AKDM5AKDM2BKDM4CKDM5B
SCHEMBL697709 0.90 LMNA (0.34) LMNAPOLBALDH1A1KDM4ESMN1; SMN2
SCHEMBL698176 0.90 GRIN2B (0.41) LMNAPOLBALDH1A1KDM4ESMN1; SMN2
SCHEMBL697262 0.89 LMNA (0.32) LMNAPOLBALDH1A1HTTKDM4E
SCHEMBL697660 0.89 NPC1 (0.38) LMNAALDH1A1HTTSMN1; SMN2NPC1
SCHEMBL697932 0.88 LMNA (0.34) LMNAPOLBALDH1A1HTTKDM4E
SCHEMBL697165 0.87 GRIN2B (0.42) LMNAPOLBALDH1A1KDM4EGRIN2B
SCHEMBL698126 0.87 GRIN2B (0.41) LMNAALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL697782 0.86 GRIN2B (0.35) LMNAPOLBALDH1A1GRIN2BKMT2A
SCHEMBL697431 0.85 MAPK14 (0.39) KDM5AKDM4CKDM5BALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 KDM4A 836/4885KDM5A 1232/4885KDM2B 489/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 KDM4A 836/4885KDM5A 1232/4885KDM2B 489/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 KDM4A 836/4885KDM5A 1232/4885KDM2B 489/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 KDM4A 836/4885KDM5A 1232/4885KDM2B 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.